Tumor lysates-constructed hydrogel to potentiate tumor immunotherapy
Journal of Controlled Release · 2023-06 · 358 · 345-357
DOI: 10.1016/j.jconrel.2023.05.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Controlled Release, 2023-06. Verfasst von Xiangwu Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jina…. Hauptthemen laut MEDLINE: Hydrogels, Neoplasms. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
T cell-based immunotherapy (TCBI) is an emerging approach to combat tumors. However, the outcome of TCBI is still far from satisfaction clinically, owing to stumbling blocks from insufficient immunogenicity, T cell exhaustion and immune evasion from programmed death-1/programmed death-ligand 1 (PD-1/PD-L1) pathway. Herein, an injectable tumor lysates-constructed hydrogel is reported to address these issues. Chemically modified tumor lysates are, for the first time, designed as the gelator to intratumorally construct hydrogel, achieving a robust antigen reservoir to induce strong immunogenicity. Meanwhile, hydrogel-encapsulated nicotinamide riboside and SB415286 enable strong mitophagy in T cells to prevent their exhaustion as well as powerfully genetical suppression of PD-1 expression to regulate immune evasion. Thus, our injectable hydrogel creates a robust immune niche within tumor, enabling to significantly potentiate TCBI. Our strategy pharmacologically regulates body's own T cells in situ, demonstrating potent immunotherapeutic effects and offering a conceptually new approach for TCBI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
- Department of Clinical Pharmacy, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, China. Electronic address: weixu@sdu.edu.cn.
- Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China. Electronic address: yuejiang@sdu.edu.cn.
- Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China. Electronic address: yuxialuan@sdu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Chen, X., Jiang, Z., Lin, Y., Yu, C., Nie, X., Xu, G., Xu, W., Jiang, Y., & Luan, Y. (2023). Tumor lysates-constructed hydrogel to potentiate tumor immunotherapy. Journal of Controlled Release, 358, 345-357. https://doi.org/10.1016/j.jconrel.2023.05.005
Vancouver
Chen X, Jiang Z, Lin Y, Yu C, Nie X, Xu G, et al. Tumor lysates-constructed hydrogel to potentiate tumor immunotherapy. Journal of Controlled Release. 2023;358:345-357. doi:10.1016/j.jconrel.2023.05.005
BibTeX
@article{Chen2023,
author = {Chen, Xiangwu and Jiang, Zeyu and Lin, Yang and Yu, Cancan and Nie, Xinxin and Xu, Guixiang and Xu, Wei and Jiang, Yue and Luan, Yuxia},
title = {Tumor lysates-constructed hydrogel to potentiate tumor immunotherapy},
journal = {Journal of Controlled Release},
year = {2023},
volume = {358},
pages = {345--357},
doi = {10.1016/j.jconrel.2023.05.005}
}
EUVIMED